✦ LIBER ✦

Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab

✍ Scribed by Kurebayashi, Junichi; Kanomata, Naoki; Yamashita, Tetsumasa; Shimo, Toshiro; Mizutoh, Akiko; Moriya, Takuya; Sonoo, Hiroshi

Book ID: 120959166
Publisher: Springer Japan
Year: 2013
Tongue: English
Weight: 412 KB
Volume: 22
Category: Article
ISSN: 1340-6868
DOI: 10.1007/s12282-013-0478-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant Trastuzumab in HER2-Positive Br

Adjuvant Trastuzumab in HER2-Positive Breast Cancer

✍ Slamon, Dennis; Eiermann, Wolfgang; Robert, Nicholas; Pienkowski, Tadeusz; Marti 📂 Article 📅 2011 🏛 Massachusetts Medical Society 🌐 English ⚖ 713 KB

Trastuzumab after Adjuvant Chemotherapy

Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer

✍ Piccart-Gebhart, Martine J.; Procter, Marion; Leyland-Jones, Brian; Goldhirsch, 📂 Article 📅 2005 🏛 Massachusetts Medical Society 🌐 English ⚖ 149 KB

744: Clinical and histopathological char

744: Clinical and histopathological characteristics of HER2-positive breast cancer in patients treated with adjuvant trastuzumab

✍ Jurcic, P. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 63 KB

2–47 Trastuzumab After Adjuvant Chemothe

2–47 Trastuzumab After Adjuvant Chemotherapy in HER2-Positive Breast Cancer

📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Continued trastuzumab therapy for patien

Continued trastuzumab therapy for patients with HER2-positive breast cancer

✍ F. Haslbauer 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Outcome impact of PIK3CA mutations in HE

Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with trastuzumab

✍ Cizkova, M; Dujaric, M-E; Lehmann-Che, J; Scott, V; Tembo, O; Asselain, B; Pierg 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 247 KB